The World Health Organization considers the Zika virus (ZIKV) outbreak in the Americas a global public health emergency. The neurologic complications due to ZIKV infection comprise microcephaly, meningoencephalitis, and Guillain-Barré syndrome. We describe a fatal case of an adult patient receiving an immunosuppressive regimen following heart transplant. The patient was admitted with acute neurologic impairment and experienced progressive hemodynamic instability and mental deterioration that finally culminated in death. At autopsy, a pseudotumoral form of ZIKV meningoencephalitis was confirmed. Zika virus infection was documented by reverse trancriptaseepolymerase chain reaction, immunohistochemistry, and immunofluorescence and electron microscopy of the brain parenchyma and cerebral spinal fluid. The sequencing of the viral genome in this patient confirmed a Brazilian ZIKV strain. In this case, central nervous system involvement and ZIKV propagation to other organs in a disseminated pattern is quite similar to that observed in other fatal Flaviviridae viral infections.
Z ika virus (ZIKV) is a mosquito-borne, single-stranded RNA arbovirus, a member of the Flaviviridae family, which includes dengue fever, yellow fever, and West Nile viruses. Zika virus was identified in the 1940s in Africa and confirmed in Brazil in May 2015. 1 Previously responsible for major epidemics, ZIKV is now spreading rapidly in the Americas, particularly Brazil, where an increased number of neonatal microcephaly cases are being reported. 2 The potential relationship between ZIKV and congenital abnormalities (eg, microcephaly) has led the World Health Organization to declare the ZIKV epidemic as a global public health emergency. 3 The clinical findings of ZIKV are similar to other mosquito-borne virusesdfever, myalgia, maculopapular rash, headache, arthralgia, and conjunctivitis. 4 Recent reports suggest that although the course of disease is often selflimiting, there is a growing concern about neurologic manifestations beyond neonatal microcephaly, such as meningoencephalitis and Guillain-Barré syndrome. [5] [6] [7] We present a case of an adult patient receiving an immunosuppressive regimen after heart transplant who was admitted with acute onset of neurologic impairment due to ZIKV infection. Our discussion includes details of pathologic analyses and virologic confirmation.
REPORT OF CASE
Eight months following heart transplant because of Chagas cardiomyopathy, a 36-year-old man was admitted to Clinic Hospital of Ribeirão Preto. The patient presented with a 2-day history of high-grade fever (2-3 times a day), malaise, headache, and seizures. His wife and his son also presented with fever and malaise, both of whom had a maculopapular rash but no neurologic symptoms. Before hospitalization, the patient was receiving standard immunosuppression (tacrolimus, prednisone, and mycophenolate mofetil) after a heart transplant. On admission, the patient had a generalized seizure with a prolonged postictal period and transitory left-sided hemiplegia. He was hemodynamically stable and had no meningeal signs.
The patient underwent a neurologic consultation and magnetic resonance imaging (MRI) to assist in the differential diagnosis (ie, Todd palsy vs stroke). The MRI was performed using a 3-T MRI unit (Achieva X-Series, Philips Healthcare,) with 32-channel sensitivity-encoding head coil and automatic intravenous injection of 20 mL of gadolinium-based contrast medium (gadoterate meglumine) at 3.5 mL/s. The MRI revealed a low apparent diffusion coefficient (arrow on Figure 1 , D) and low cerebral blood flow (arrow on Figure 1 , H) with cytotoxic cortical edema surrounded by vasogenic edema, hyperintense on T2-weighted imaging (Figure 1, B) and fluid-attenuated inversion recovery (Figure 1, C) . During the hour following MRI, the patient's neurologic deficit partially recovered. Antibiotics, acyclovir, lamotrigine, and valproic acid were initiated. With a diagnosis of viral encephalitis and concomitant lymphopenia, immunosuppressive therapy had to be withdrawn with the exception of methylprednisolone. Results of electrocardiography, echocardiography, and electroencephalography were unremarkable. On the same day, a lumbar puncture was performed; cerebrospinal fluid (CSF) examination revealed 2 cells/mL (only lymphocytes), a high protein level, and a normal glucose level. Ancillary laboratory tests and reverse transcriptaseepolymerase chain reaction (RT-PCR) for infectious agents were also performed. The RT-PCR results from CSF were negative for Toxoplasma gondii, human herpesvirus types 1, 2, and 6, polyomavirus, Epstein-Barr virus, cytomegalovirus, varicella zoster, dengue virus, and enterovirus. The only positive RT-PCR result in the CSF was for ZIKV, confirming a putative diagnosis of central nervous system (CNS) ZIKV infection.
After 1 week of hospitalization in the intensive care unit, the patient still had 3 to 4 daily episodes of fever (37.8 C-38.4 C) and had progressive worsening of neurologic symptoms (ie, headache, confusion, and hallucinations). Given the persistent neurologic status, MRI and lumbar puncture were repeated. The findings of the second CSF analysis were suggestive of meningitis: (1) leukocyte count, 58 cells/mL with 100% lymphocytes; protein level, 105.37 mg/dL; and CSF to blood glucose ratio, 0.41. Compared with results of the first examination, the second MRI revealed a mild reduction in the compromised area. Despite no evidence of bacterial infection, the patient was hemodynamically unstable. Noradrenaline, vancomycin, and meropenem were administered but produced no electroencephalographic changes. On the 10th day of hospitalization, atrial fibrillation occurred, and cardiac rejection was suspected. Intravenous amiodarone and pulse therapy with high-dose methylprednisolone were started. Subsequently, the patient had signs of low cardiac output with worsening peripheral blood perfusion and elevated plasma lactate levels. Despite inotropic therapy with dobutamine, the patient experienced refractory circulatory shock followed by cardiac arrest with pulseless electrical activity and died. The cause of death was cardiogenic shock due to acute cardiac allograft rejection. Additional laboratory testing and an autopsy were subsequently performed.
METHODS

Laboratory Testing and Microbiological Investigation
The RNA of the CSF and the brain of the patient were extracted using the QIAamp viral RNA extraction kit (QIAGEN) according to the manufacturer's specifications. Seventy-six nucleotides of the ZIKV NS5 gene were amplified from the RNA extract of the CSF by a conventional ZIKV-specific RT-PCR, as previously described by Lanciotti et al. 8 Nucleotides of the amplicon were sequenced using the BigDye Terminator v3.1 Cycle Sequencing 5X Kit (Applied Biosystems,). The reaction was performed using the ABI PRISM 3100 Genetic Analyzer (Applied Biosystems).
Autopsy
An autopsy was performed 6 hours after the patient's death with extensive sampling of organs. Tissue samples were fixed for 1 day in 4% buffered formalin and embedded in paraffin blocks. Sections were stained with hematoxylin-eosin for microscopic evaluation.
Electron Microscopy
Small tissue fragments from the right frontal cortex were collected during the autopsy. Small blocks (1 mm   3 ) were fixed in 2% glutaraldehyde/2% paraformaldehyde in cacodylate buffer overnight, postfixed in 1% osmium tetroxide, dehydrated, and embedded in plastic resin. Ultrathin sections obtained from selected areas were double-stained with uranyl acetate and lead citrate and examined in a Zeiss EM 109 electron microscope (Carl Zeiss Meditec, Inc) at 80 kV.
Immunohistochemistry and Immunofluorescence
Briefly, for CD8 lymphocyte and microglial cell detection by immunohistochemistry, sections were incubated for 2 hours at room temperature with a mouse primary antibody specific for ZIKV produced by the Center for Virology Research of the Medical School of Ribeirão Preto at the University of São Paulo, Brazil (dilution 1:100), CD8 antibody (UCH-T4, Santa Cruz Biotechnology Inc; dilution 1:100), and CD68 antibody (ED1, Santa Cruz Biotechnology Inc; dilution 1:100), followed by incubation with a biotinylated pan-specific universal secondary antibody (VECTASTAIN Universal Elite ABC Kit, Vector Laboratories Inc) for 30 minutes. This secondary antibody is a mouse immune ascetic fluid collected from mice immunized 4 times intraperitoneally with ZIKV from mouse brain macerate in saline solution. 9 Thus, the ascetic fluid contained only polyclonal antibodies to multiple epitopes of the virus. The mouse polyclonal antibody reacts strongly with cultured cells infected with ZIKV. Next, the slides were incubated with the avidin-biotin-peroxidase complex (VECTASTAIN) for 30 minutes and developed with a 3,3 0 -diaminobenzidine kit (Vector Laboratories Inc) for 5 minutes. Finally, slides were counterstained with Harris hematoxylin, dehydrated, and mounted with Permount (Biomeda Corporation). Other autopsy samples without ZIKV infection were incubated with the same antibody under identical conditions as negative controls.
Frozen samples were also sectioned for immunofluorescence analysis using the same primary antibody (dilution 1:100), but in this case, the labeling was detected by fluorescein conjugated streptavidin. Other autopsy samples without ZIKV infection were also incubated with the same antibody under identical conditions as negative controls.
RESULTS
Laboratory Testing and Microbiological Investigation
The nucleotide sequence of ZIKV isolated from the brain tissue showed 100% identity with the Brazilian ZIKV strain BeH828305 (KU729217AE2), based on the Basic Local Alignment Search Tool.
Organs and tissues (brain, lung, and heart) of the patient were homogenized using a QIAGEN TissueLyser II machine (QIAGEN NV) (30 Hz by 10 minutes) in 1 mL of minimum essential medium. Following centrifugation, supernatants were submitted to the QIAamp viral RNA extraction kit (QIAGEN) according to manufacturer's specifications. The amplicon containing 76 base pairs was sequenced, and this sequence was submitted to the US National Center for Biotechnology Information's Basic Local Alignment Search Tool, which confirmed that it was from ZIKV. 8 
Autopsy and Neuropathologic Findings
Examination of the skull contents revealed opalescence of leptomeninges of the brain convexity. The brain weighed 1593.9 g, and gross examination revealed severe edema (ie, flattened cerebrocortical gyri with narrow sulci). Examination of coronal brain sections yielded unremarkable findings, except for a right frontal tumorlike lesion involving the motor cortex area (Figure 2) . Microscopically, the subarachnoid space revealed a moderate lymphomononuclear infiltrate composed predominantly of CD8 þ T lymphocytes and, to a lesser extent, monocytes/macrophages (CD68 þ ), CD4 þ T lymphocytes, and a few B lymphocytes as well as fibrin deposits. In the brain parenchyma of the right motor cortex, CD8 þ T lymphocytes were the predominant inflammatory cell type, spread throughout the neuropil and within the Virchow-Robin spaces, including deeper venules (Figure 2 ). Isolated microglial cells and CD4 þ T lymphocytes were also present, and the CD8 þ to CD4 þ T lymphocyte ratio was 5-6:1. However, microglial nodules were normal, with occasional evidence of neuronophagia, mainly in the right motor cortex where CD8 þ T cells were invariably present ( Figure 2 ). Regarding to the other regions of the brain, occasional microglial nodules and very few inflammatory CD8 þ and CD4 þ T lymphocytes and microglial cells were observed in the neocortex and basal ganglia as well as throughout the brain stem, including the cervical spinal cord and cerebellar cortex (data not shown).
The heart was enlarged (630 g) and included a moderate amount of inflammatory infiltrate of mononuclear predominance, rich in plasma cells permeating through the muscle fibers mainly around vessels with aggression to the vascular endothelium, compatible with acute cardiac cellular rejection (Figure 2) . Additionally, we found cytoplasmic staining for ZIKV in some epithelia (eg, bronchial and biliary) that probably represents a nonspecific staining of nuclear antigens by the antibody used in the analysis. The ZIKV was also found in inflammatory cells within the CNS as well as in the heart, liver, and lung.
Electron Microscopy
Transmission electron microscopy revealed clusters of spherical virions harboring morphological features consistent with Flaviviridae viruses (Figure 3 ) in the cytoplasm of macrophages, which were placed around small vessels. The virion particles are associated with the endoplasmic reticulum. We did not find viral particles in neurons or glial cells.
DISCUSSION
The ZIKV infection in the Americas is expected to spread and affect millions, 10, 11 with an unpredictable clinical impact, particularly in immunocompromised patients. Considering the exposure of vulnerable people (those with AIDS, transplants, and chronic diseases and elderly persons) to ZIKV vectors, the potential impact of the ZIKV outbreak in Third World countries may be catastrophic. To the best of our knowledge, this case is the first description of severe CNS involvement of ZIKV infection in an immunocompromised patient. In adults, neurologic involvement of ZIKV infection is reported mainly related to Guillain-Barré syndrome, which was reported to be 20-fold higher during the French Polynesian outbreak but not followed by fatalities. 12 In the current case, the positive RT-PCR investigation for ZIKV from the CSF and brain tissue collected at the tumorlike lesion involving the right motor cortex during autopsy confirmed the diagnosis of CNS ZIKV infection. 11 These results were consistent with immunohistochemistry, immunofluorescence, and electron microscopy findings and strongly suggest a key clinical presentation for the ZIKV. Similarly, another case with possible ZIKV-related meningoencephalitis was recently reported. 6 Moreover, the ZIKV in other organs, such as the lungs and liver, was another novel finding in this case of an immunocompromised patient. However, its relationship to the cause of death or organ dysfunction is not clear. Human dermal fibroblasts, epidermal keratinocytes, and immature dendritic cells have been reported to be permissive to ZIKV infection, 13 and our immunofluorescence results corroborate this finding. Data about the presence of ZIKV in other organs are scarce and require further investigation. Intriguingly, other ZIKV nonvector routes of transmission have been described, such as sexual and peripartum transmission.
11
Although the clinical features of the ZIKV infection are not completely understood, findings from experimental models conducted in the 1950s and from recent reports suggest that the neurotropism of ZIKV may cause neural cell death that is possibly related to microcephaly in infants. In adults, Guillain-Barré syndrome and other neurologic impairment are more often described in ZIKV infection, which corroborates the hypothesis that neural lesions may be caused by sensitized T cells in an abnormal inflammatory process. 5, 7, 14 In the present case, the microscopic examination of the CNS revealed perivascular inflammation, microglial nodules, and neuronophagia, more restricted to the right motor cortex generating a pseudotumoral lesion where CD8
þ T cells and activated microglia (CD68 þ ) were invariably present. Taken together, the CNS involvement and ZIKV spreading to the other organs in a disseminated pattern is quite similar to that observed in other Flaviviridae virus infections 15 such as Rocio and Saint Louis encephalitis viruses and particularly the West Nile neuroinvasive disease, the neuropathology of which is also characterized by a pattern of microglial nodules, perivascular inflammatory infiltrates, and neuronophagia. 16 However, on MRI in our case, the majority of the injury was localized to the cingulate and superior frontal gyrus with extension into subcortical white matter, whereas the topography of the West Nile neuroinvasive disease's neuropathology has a clear predilection for gray matter areas of the brain stem, particularly the medulla and spinal cord, as well as infection of pyramidal motor neurons of the anterior horns and cerebellar Purkinje cells, 17 usually sparing cortical tissue, features that we did not observe in this case.
Interestingly, except for the subarachnoid afflux of lymphomononuclear cells, the remaining brain parenchyma had only mild changes, such as occasional microglial nodules and very few inflammatory CD8 þ and CD4 þ T lymphocytes. Hypothetically, these findings might be caused by the suspension of the patient's immunosuppressive regimen. Given the limited available information, the present case illustrates a difficult clinical dilemma regarding the management of ZIKV infection in immunosuppressed patients. Similarly, the West Nile virus appears to affect the elderly and immunocompromised patients, and currently, treatment options remain supportive, as in other Flavivirus infections in the CNS. Of greatest concern is the need to reduce or withdraw immunosuppressive drugs in this clinical scenario, mainly because of its potential negative impact on the clinical course of the viral infection, as previously described in other Flaviviridae infections in immunocompromised pediatric patients. 18, 19 This management strategy should avoid fully withdrawing immunosuppressive therapy in order to not precipitate an acute rejection episode that could lead to serious adverse outcomes, as apparently happened in this case.
CONCLUSION
The ZIKV infection is a global public health emergency. There is limited available information about the ZIKV infection or neurologic involvement in immunocompromised patients. We described a fatal case with a severe neurologic impairment due to ZIKV infection in an adult patient receiving an immunosuppressive regimen following a heart transplant. The clinical management illustrates a difficult dilemma due to the concern of fully withdrawing the immunosupressive therapy, which should be avoided in order to not precipitate an acute rejection episode, as apparently happened in this case.
